CIK: 0002003159 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 4, 2026
Total Value ($000): $16,543 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 11,818 | $3,253 | 19.7% | $279.23 | 0.0% | COM | 125523100 |
| ARVN | ARVINAS INC | 166,342 | $1,973 | 11.9% | $10.92 | 0.0% | COM | 04335A105 |
| ABVX | ABIVAX SA | 14,375 | $1,939 | 11.7% | $134.86 | — | SPONSORED ADS | 00370M103 |
| IQV | IQVIA HLDGS INC | 8,183 | $1,845 | 11.1% | $217.58 | 0.0% | COM | 46266C105 |
| MRVI | MARAVAI LIFESCIENCES HLDGS I | 457,707 | $1,488 | 9.0% | $3.37 | 0.0% | COM CL A | 56600D107 |
| — | ATAI BECKLEY NV | 234,915 | $961 | 5.8% | $4.09 | — | SHS | N0731H103 |
| SLNO | SOLENO THERAPEUTICS INC | 8,741 | $405 | 2.4% | $54.83 | 0.0% | COM | 834203309 |
| KLTO | KLOTHO NEUROSCIENCES INC | 606,757 | $175 | 1.1% | $0.48 | 0.0% | COM | 49876K103 |
| FHTX | FOGHORN THERAPEUTICS INC | 4,708 | $25 | 0.2% | $4.53 | 0.0% | COM | 344174107 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BDX | BECTON DICKINSON & CO | 5,176 (+1001.3%) | $1,005 (+1041.9%) | 6.1% | $189.05 | +0.3% | COM | 075887109 |
| NMRK | NEWMARK GROUP INC | 200,493 (+5.8%) | $3,477 (-1.6%) | 21.0% | $16.26 | +7.6% | CL A | 65158N102 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PTCT | PTC THERAPEUTICS INC | 19,142 | $1,175 | 7.1% | $52.09 | +39.5% | — | 69366J200 |
| CIGI | COLLIERS INTL GROUP INC | 4,426 | $691 | 4.2% | $153.63 | -2.3% | — | 194693107 |